Literature DB >> 18514033

Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse.

John L Svenson1, Jackie EuDaly, Phil Ruiz, Kenneth S Korach, Gary S Gilkeson.   

Abstract

Systemic lupus erythematosus (SLE) occurs nine times more often in females than males. The purpose of this study was to determine the impact of estrogen receptor (ER) null genotypes on disease in lupus prone NZM2410 (NZM) and MRL/lpr mice, as a method to define the role of estrogen receptor signaling in lupus. ER alpha deficient NZM females, but not males, had significantly prolonged survival, reduced proteinuria, renal pathology scores and serum urea nitrogen levels compared to wildtype mice, despite higher serum anti-dsDNA levels. ER alpha deficient MRL/lpr female, but not male, mice also had significantly less proteinuria and renal pathology scores with no effect on autoantibody levels. Deficiency of ER beta had no effect on disease in either strain or sex. Taken together, these data demonstrate a key role for ER alpha, but not ER beta, in the development of lupus like disease, but not autoimmunity, in female NZM and MRL/lpr mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514033      PMCID: PMC4778964          DOI: 10.1016/j.clim.2008.03.508

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  24 in total

Review 1.  Update on systemic lupus erythematosus: autoantibodies and apoptosis.

Authors:  C Gordon; M Salmon
Journal:  Clin Med (Lond)       Date:  2001 Jan-Feb       Impact factor: 2.659

2.  Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta.

Authors:  John F Couse; Mariana M Yates; Vickie R Walker; Kenneth S Korach
Journal:  Mol Endocrinol       Date:  2003-03-06

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  Sex steroid hormones and systemic lupus erythematosus.

Authors:  N Talal
Journal:  Arthritis Rheum       Date:  1981-08

Review 5.  Sex hormones and modulation of immune response in SLE.

Authors:  N Talal
Journal:  Clin Rheum Dis       Date:  1982-04

Review 6.  Mechanisms of estrogen action.

Authors:  S Nilsson; S Mäkelä; E Treuter; M Tujague; J Thomsen; G Andersson; E Enmark; K Pettersson; M Warner; J A Gustafsson
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

7.  Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain.

Authors:  L Morel; Y Yu; K R Blenman; R A Caldwell; E K Wakeland
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

Review 8.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

Authors:  S Ansar Ahmed; W J Penhale; N Talal
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

9.  Estrogen alters thresholds for B cell apoptosis and activation.

Authors:  Christine M Grimaldi; James Cleary; A Selma Dagtas; Dariush Moussai; Betty Diamond
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice.

Authors:  H Carlsten; A Tarkowski; R Holmdahl; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

View more
  44 in total

1.  Differential roles of estrogen receptors α and β in control of B-cell maturation and selection.

Authors:  Latia Hill; Venkatesh Jeganathan; Prameladevi Chinnasamy; Christine Grimaldi; Betty Diamond
Journal:  Mol Med       Date:  2010-11-22       Impact factor: 6.354

Review 2.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

3.  Bisphenol A (BPA) stimulates the interferon signaling and activates the inflammasome activity in myeloid cells.

Authors:  Ravichandran Panchanathan; Hongzhu Liu; Yuet-Kin Leung; Shuk-mei Ho; Divaker Choubey
Journal:  Mol Cell Endocrinol       Date:  2015-08-12       Impact factor: 4.102

Review 4.  Can estrogens promote hypertension during systemic lupus erythematosus?

Authors:  Marcia Venegas-Pont; Michael J Ryan
Journal:  Steroids       Date:  2010-02-21       Impact factor: 2.668

Review 5.  Estrogen receptors in immunity and autoimmunity.

Authors:  Melissa Cunningham; Gary Gilkeson
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 6.  Estrogen Receptors: New Directions in the New Millennium.

Authors:  Sylvia C Hewitt; Kenneth S Korach
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 7.  The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells.

Authors:  Eszter Baricza; Viola Tamási; Nikolett Marton; Edit I Buzás; György Nagy
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

8.  The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.

Authors:  S Sato; X K Zhang
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 9.  Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.

Authors:  E Kassi; P Moutsatsou
Journal:  J Biomed Biotechnol       Date:  2010-06-10

Review 10.  The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management.

Authors:  Ebru Karpuzoglu; Moncef Zouali
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.